CCCC SCHEDULE 13G/A: SEC filing
Squadron Capital
Filed with the SEC on · accession 0002050709-26-000022
CCCC filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. Squadron Capital filed an amended Schedule 13G (13G/A) regarding its passive ownership stake in C4 Therapeutics, Inc. (CCCC). The stock moved +3.9% by the first close after the filing.
Summary of the filing
Squadron Capital filed an amended Schedule 13G (13G/A) regarding its passive ownership stake in C4 Therapeutics, Inc. (CCCC). The filing indicates a change in the reporting person's beneficial ownership position.
Key details
How CCCC stock reacted
Close before
$4.08
Aug 13, 2026
First close after
+3.92%
$4.24
5 trading days
-1.23%
$4.03
Since filing
-24.02%
$3.10
✦ Ask GOAX AI about this filing — what it means for CCCC, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CCCC?
Click hereFrequently asked questions
What did CCCC file with the SEC on Aug 14, 2026?
CCCC filed a SCHEDULE 13G/A (SEC filing). Squadron Capital filed an amended Schedule 13G (13G/A) regarding its passive ownership stake in C4 Therapeutics, Inc. (CCCC). The filing indicates a change in the reporting person's beneficial ownership position.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did CCCC stock react to this filing?
CCCC closed at $4.08 before the filing and $4.24 on Aug 14, 2026 (+3.92%). Five trading days later: $4.03 (-1.23%).
Other CCCC SEC filings
- 10-Q · SEC filingNov 5, 2026
- 8-K · SEC filingNov 5, 2026
- 8-K · Fda approvalSep 25, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 12, 2026
- 10-Q · SEC filingAug 11, 2026
- 8-K · SEC filingAug 11, 2026
- 8-K · SEC filingJun 24, 2026
- 8-K · Fda approvalJun 11, 2026
Get alerts when CCCC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days